Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Proteome Research

• Publication date

  2015-02-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/pr500973dPMID 25483141
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bile acid signaling and liver regeneration.

  2015cited by this paper
• Differential Neuroprotective Effects of 5′-Deoxy-5′-Methylthioadenosine

  2014cited by this paper
• Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics.

  2014cited by this paper
• Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.

  2014cited by this paper
• Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis

  2014cited by this paper
• Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry.

  2014cited by this paper
• NMR and LC/MS‐based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis

  2014cited by this paper
• Investigation of the relationship between the metabolic profile of tobacco leaves in different planting regions and climate factors using a pseudotargeted method based on gas chromatography/mass spectrometry.

  2013cited by this paper
• S-adenosylmethionine metabolism and liver disease.

  2013cited by this paper
• Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors.

  2013cited by this paper
• Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma

  2013cited by this paper
• Integrated Systems and Technologies Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics

  2013cited by this paper
• Urinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometry.

  2013cited by this paper
• The profile of bile acids and their sulfate metabolites in human urine and serum.

  2013cited by this paper
• Rapid and sensitive HILIC–MS/MS analysis of carnitine and acetylcarnitine in biological fluids

  2013cited by this paper
• Pseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometry.

  2013cited by this paper
• Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.

  2012cited by this paper
• Urine metabolomics.

  2012cited by this paper
• Carnitine and Acylcarnitines

  2012cited by this paper
• A novel approach to transforming a non-targeted metabolic profiling method to a pseudo-targeted method using the retention time locking gas chromatography/mass spectrometry-selected ions monitoring.

  2012cited by this paper
• Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.

  2012cited by this paper
• LC-MS metabolomics of polar compounds.

  2012cited by this paper
• Liquid chromatography-mass spectrometry-based metabolomic analysis of livers from aged rats.

  2012cited by this paper
• Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics

  2012cited by this paper
• Urinary hydrophilic and hydrophobic metabolic profiling based on liquid chromatography‐mass spectrometry methods: Differential metabolite discovery specific to ovarian cancer

  2012cited by this paper
• Urinary acylcarnitines are altered in human kidney cancer

  2012cited by this paper
• Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).

  2011cited by this paper
• Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling.

  2011cited by this paper
• 1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis

  2011cited by this paper
• Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.

  2011cited by this paper
• Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.

  2011cited by this paper
• Metabolomics Study of Stepwise Hepatocarcinogenesis From the Model Rats to Patients: Potential Biomarkers Effective for Small Hepatocellular Carcinoma Diagnosis*

  2011cited by this paper
• Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases

  2011cited by this paper
• Helicobacter hepaticus--induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial-induced immune response.

  2011cited by this paper
• Present and future possibilities for early diagnosis of hepatocellular carcinoma.

  2010cited by this paper
• Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.

  2009cited by this paper
• A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry.

  2009cited by this paper
• Normalization strategies for metabonomic analysis of urine samples.

  2009cited by this paper
• Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.

  2009cited by this paper
• Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.

  2009cited by this paper
• Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.

  2009cited by this paper
• Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics

  2009cited by this paper
• Nonalcoholic fatty liver disease and mitochondrial dysfunction.

  2008cited by this paper
• Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information.

  2008cited by this paper
• Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements

  2008cited by this paper
• Quantitative mass spectrometry in proteomics: a critical review

  2007cited by this paper
• Role of S‐adenosyl‐L‐methionine in liver health and injury

  2007cited by this paper
• Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.

  2007cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• Mass spectrometry-based metabolomics.

  2007cited by this paper
• Fusion of mass spectrometry-based metabolomics data.

  2005cited by this paper
• Metabolomics: Current analytical platforms and methodologies

  2005cited by this paper
• Identification and quantification of Nɛ-(Hexanoyl)lysine in human urine by liquid chromatography/tandem mass spectrometry

  2004cited by this paper
• Urinary Creatinine Concentrations in the U.S. Population: Implications for Urinary Biologic Monitoring Measurements

  2004cited by this paper
• Identification and quantification of N(epsilon)-(Hexanoyl)lysine in human urine by liquid chromatography/tandem mass spectrometry.

  2004cited by this paper
• Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases.

  2004cited by this paper
• Metabolomics – the link between genotypes and phenotypes

  2004cited by this paper
• Glutamine and glutamate—their central role in cell metabolism and function

  2003cited by this paper
• Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma

  2002cited by this paper
• Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation.

  1999cited by this paper
• Urinary nucleosides.

  1998cited by this paper
• Abnormal methylation capacity in human liver cirrhosis.

  1988cited by this paper
• Plasma amino-acid patterns in liver disease.

  1982cited by this paper
• Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors.

  1976cited by this paper
• Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2).

  1976cited by this paper
• Protein metabolism of tissue cells in vitro; the chemical nature of some obligate factors of tissue cell nutrition.

  1949cited by this paper

• Multi-omics biomarker detection in Diethylnitrosamine (DENA) induced hepatocellular carcinoma.

  2026cites this paper
• Porous Silicon Particle-Assisted Mass Spectrometry Technology Unlocks Serum Metabolic Fingerprints in the Progression From Chronic Hepatitis B to Hepatocellular Carcinoma.

  2025cites this paper
• Resolution-Adaptive Binning Enhances Machine Learning Modeling by Interbatch and Multiplatform Orbitrap-Based Shotgun Mass Spectrometry Data Integration

  2025cites this paper
• Urinary biomarkers in cancer detection: explorations, advancements, challenges, and future directions.

  2025cites this paper
• In-depth analysis of Pseudotargeted metabolomics strategy: Multi-field applications, advantages and challenges

  2025cites this paper
• Cross-Referencing Multifluid Metabolic Profiles on Hollow Dodecahedral Nanocages for Enhanced Disease Status Identification.

  2025cites this paper
• Multiscale Structured Trimetal Oxide Heterojunctions for Urinary Metabolic Phenotype‐Dependent Screening of Early and Small Hepatocellular Carcinoma

  2024cites this paper
• Altered Metabolites in Hepatocellular Carcinoma (HCC) Paving the Road for Metabolomics Signature and Biomarkers for Early Diagnosis of HCC

  2024cites this paper
• Determination of bioactive substances in 27 edible flowers based on LC-MS/MS

  2024cites this paper
• Metabolomics for searching validated biomarkers in cancer studies: a decade in review

  2024cites this paper
• Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review.

  2024cites this paper
• Strategy for Comprehensive Detection and Annotation of Gut Microbiota-Related Metabolites Based on Liquid Chromatography-High-Resolution Mass Spectrometry.

  2024cites this paper
• Circulating Biomarkers for the Early Diagnosis and Management of Hepatocellular Carcinoma with Potential Application in Resource-Limited Settings

  2023cites this paper
• Comprehensive spectroscopic, metabolomic, and proteomic liquid biopsy in the diagnostics of hepatocellular carcinoma.

  2023cites this paper
• Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians

  2023influential citation
• Machine learning facilitates the application of mass spectrometry-based metabolomics to clinical analysis: A review of early diagnosis of high mortality rate cancers

  2023cites this paper
• Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study

  2023cites this paper
• Pseudotargeted metabolomics-based random forest model for tracking plant species from herbal products.

  2023cites this paper
• OSCA-finder: Redefining the assay of kidney disease diagnostic through metabolomics and deep learning.

  2023cites this paper
• A pseudotargeted peptidomics strategy for screening natural signature peptides in animal-derived drugs: Taking Pheretima as a case

  2023cites this paper
• Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine

  2023cites this paper
• Optimised systematic review tool: Application to candidate biomarkers for the diagnosis of hepatocellular carcinoma.

  2022cites this paper
• Urinary Metabolic Pro�ling of Liver Fluke-induced Cholangiocarcinoma – a Validation Study

  2022cites this paper
• Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma—A Follow-Up Study

  2022cites this paper
• A New Strategy Based on LC-Q TRAP-MS for Determining the Distribution of Polyphenols in Different Apple Varieties

  2022cites this paper
• A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer

  2022cites this paper
• Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study

  2022cites this paper
• Nanoconfined liquid phase nanoextraction combined with in-fiber derivatization for simultaneous quantification of seventy amino-containing metabolites in plasma by LC-MS/MS: Exploration of lung cancer screening model.

  2022cites this paper
• Metabolic Footprinting of Microbial Systems Based on Comprehensive In Silico Predictions of MS/MS Relevant Data

  2022cites this paper
• Evaluation of meibum lipid composition according to tear interferometric patterns.

  2022cites this paper
• Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy

  2022cites this paper
• Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer

  2022cites this paper
• Metabolomic biomarkers for hepatocellular carcinoma

  2022cites this paper
• 1H-NMR-based metabolomics reveals the biomarker panel and molecular mechanism of hepatocellular carcinoma progression

  2022cites this paper
• Metabolomic Biomarkers in Parkinson’s Disease

  2022cites this paper
• Urinary Metabolic Biomarkers in Cancer Patients: An Overview.

  2021cites this paper
• 基于超高效液相色谱-飞行时间质谱法测定LAMTOR1在肝脏炎症恶性转化中调控的代谢物

  2021cites this paper
• Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study

  2021cites this paper
• Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications

  2021cites this paper
• Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma

  2021cites this paper
• A pseudotargeted method based on sequential window acquisition of all theoretical spectra MS acquisition and its application in quality assessment of traditional Chinese medicine preparation-Yuanhu Zhitong Tablet.

  2021cites this paper
• Comparison of the metabolome in urine prior and eight weeks after radical prostatectomy uncovers pathologic and molecular features of prostate cancer.

  2021cites this paper
• Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma.

  2021cites this paper
• An untargeted metabolomics approach to identify markers to distinguish duck eggs that come from different poultry breeding systems by ultra high performance liquid chromatography-high resolution mass spectrometry.

  2021cites this paper
• Current approaches to the analysis of bile and the determination of bile acids in various biological matrices as supportive tools to traditional diagnostic testing for liver dysfunction and biliary diseases

  2021cites this paper
• A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.

  2021cites this paper
• Advances in the early diagnosis of hepatocellular carcinoma

  2020cites this paper
• 1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages

  2020cites this paper
• The application of pseudotargeted metabolomics method for fruit juices discrimination.

  2020cites this paper
• Update on urine as a biomarker in cancer: a necessary review of an old story

  2020cites this paper
• Pseudotargeted Method based on Parallel Column Two-Dimensional Liquid Chromatography-Mass Spectrometry for Broad Coverage of Metabolome and Lipidome.

  2020cites this paper
• Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?

  2020cites this paper
• Development of a plasma pseudotargeted metabolomics method based on ultra-high-performance liquid chromatography–mass spectrometry

  2020cites this paper
• An improved pseudotargeted GC-MS/MS-based metabolomics method and its application in radiation-induced hepatic injury in a rat model.

  2020cites this paper
• Use of information dependent acquisition mass spectra and sequential window acquisition of all theoretical fragment-ion mass spectra for fruit juices metabolomics and authentication

  2020cites this paper
• Human Prostate Cancer Is Characterized by an Increase in Urea Cycle Metabolites

  2020cites this paper
• Plasma and stool metabolomic biomarkers of non-alcoholic fatty liver disease in Argentina

  2020cites this paper
• Bridging Targeted and Untargeted Mass Spectrometry-Based Metabolomics via Hybrid Approaches

  2020influential citation
• A green and efficient pseudotargeted lipidomics method for the study of depression based on ultra-high performance supercritical fluid chromatography-tandem mass spectrometry.

  2020cites this paper
• 世界最大級の医療研究都市Texas Medical Centerでの出会いと学び

  2020cites this paper
• Development of a metabolic pathway-based pseudo-targeted metabolomics method using liquid chromatography coupled with mass spectrometry.

  2019cites this paper
• Metabolic rearrangements in primary liver cancers: cause and consequences

  2019cites this paper
• New advances in analytical methods for mass spectrometry-based large-scale metabolomics study

  2019cites this paper
• Metabolomics by UHPLC–MS: benefits provided by complementary use of Q-TOF and QQQ for pathway profiling

  2019cites this paper
• Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma

  2019cites this paper
• Cancer metabolomic markers in urine: evidence, techniques and recommendations

  2019cites this paper
• Development and application of time staggered/mass staggered-globally optimized targeted mass spectrometry.

  2019cites this paper
• Plant Metabolomics: Sustainable Approach Towards Crop Productivity

  2019cites this paper
• Database Assisted Globally Optimized Targeted Mass Spectrometry (dGOT-MS): Broad and Reliable Metabolomics Analysis with Enhanced Identification.

  2019cites this paper
• Targeted UPLC-MS/MS high-throughput metabolomics approach to assess the purine and pyrimidine metabolism.

  2019cites this paper
• Comparison of aerial parts of Astragalus membranaceus and Astragali Radix based on chemical constituents and pharmacological effects

  2019cites this paper
• Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma

  2019cites this paper
• Microbial Metabolomics

  2019cites this paper
• Ion-Pair Selection Method for Pseudotargeted Metabolomics Based on SWATH MS Acquisition and Its Application in Differential Metabolite Discovery of Type 2 Diabetes.

  2018cites this paper
• A high throughput metabolomics method and its application in female serum samples in a normal menstrual cycle based on liquid chromatography-mass spectrometry.

  2018cites this paper
• A review of validated biomarkers obtained through metabolomics

  2018cites this paper
• Exploiting High-Resolution Mass Spectrometry for Targeted Metabolite Quantification and 13C-Labeling Metabolism Analysis.

  2018cites this paper
• Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation

  2018cites this paper
• A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

  2018cites this paper
• Metabolomic estimation of the diagnosis of hepatocellular carcinoma based on ultrahigh performance liquid chromatography coupled with time-of-flight mass spectrometry

  2018cites this paper
• Serum metabolite profiling of cutaneous T-cell lymphoma based on a multiplatform approach.

  2018cites this paper
• Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.

  2018cites this paper
• Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities

  2018cites this paper
• Diagnostic and therapeutic profiles of serum bile acids in women with intrahepatic cholestasis of pregnancy-a pseudo-targeted metabolomics study.

  2018cites this paper
• Plasma metabolic profiling analysis of Cortex Periplocae-induced cardiotoxicity based on UPLC/Q-TOF-MS

  2018cites this paper
• Metabonomics Research Progress on Liver Diseases

  2017cites this paper
• Immobilization of zirconium-glycerolate nanowires on magnetic nanoparticles for extraction of urinary ribonucleosides

  2017cites this paper
• Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules

  2017cites this paper
• Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis

  2017cites this paper
• The utility of biomarkers in hepatocellular carcinoma: review of urine-based 1H-NMR studies – what the clinician needs to know

  2017cites this paper
• The serum metabolic profiles of different Barcelona stages hepatocellular carcinoma associated with hepatitis B virus

  2017cites this paper
• Rapid differentiating colorectal cancer and colorectal polyp using dried blood spot mass spectrometry metabolomic approach

  2017cites this paper
• Hyphenated MS-based targeted approaches in metabolomics.

  2017cites this paper
• Integrated and global pseudotargeted metabolomics strategy applied to screening for quality control markers of Citrus TCMs

  2017cites this paper
• Metabolomics, a Powerful Tool for Agricultural Research

  2016influential citation
• Tailored sensitivity reduction improves pattern recognition and information recovery with a higher tolerance to varied sample concentration for targeted urinary metabolomics.

  2016cites this paper
• Lipidomic and metabolomic analysis of biological response mechanisms in cancer cells : a multidisciplinary approach

  2016cites this paper
• A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis

  2016cites this paper
• Selective adsorption of modified nucleoside cancer biomarkers by hybrid molecularly imprinted adsorbents.

  2016cites this paper
• Sample-directed pseudotargeted method for the metabolic profiling analysis of rice seeds based on liquid chromatography with mass spectrometry.

  2016cites this paper